Spago Nanomedical AB Working Capital to Net Assets Ratio
Spago Nanomedical AB working capital to net assets ratio. Spago Nanomedical AB (SPAGO) has a Working Capital to Net Assets ratio of 100.1% as of December 2025. Working capital of Skr30.77 Million (current assets of Skr35.94 Million minus current liabilities of Skr5.17 Million) is measured against net assets of Skr30.75 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Spago Nanomedical AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Spago Nanomedical AB (2011–2025)
Working capital to net assets ratio of Spago Nanomedical AB from 2011 to 2025. This chart shows how Spago Nanomedical AB's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 100.1%, reflecting working capital of Skr30.77 Million against net assets of Skr30.75 Million SEK. See SPAGO cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Spago Nanomedical AB Working Capital to Net Assets Ratio by Year (2011–2025)
Spago Nanomedical AB working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Spago Nanomedical AB from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Spago Nanomedical AB balance sheet assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.1% | Skr30.77 Million | Skr30.75 Million | Skr35.94 Million | Skr5.17 Million | ▲ +1.6 pp |
| 2024 | 98.5% | Skr32.72 Million | Skr33.23 Million | Skr38.59 Million | Skr5.86 Million | ▲ +0.6 pp |
| 2023 | 97.9% | Skr40.43 Million | Skr41.32 Million | Skr51.91 Million | Skr11.48 Million | ▲ +69.2 pp |
| 2022 | 28.6% | Skr56.45 Million | Skr197.16 Million | Skr65.24 Million | Skr8.80 Million | ▲ +2.9 pp |
| 2021 | 25.7% | Skr47.58 Million | Skr184.81 Million | Skr54.39 Million | Skr6.81 Million | ▲ +9.0 pp |
| 2020 | 16.7% | Skr26.69 Million | Skr159.67 Million | Skr29.83 Million | Skr3.15 Million | ▲ +9.0 pp |
| 2019 | 7.8% | Skr10.67 Million | Skr137.63 Million | Skr13.58 Million | Skr2.91 Million | ▼ -3.0 pp |
| 2018 | 10.7% | Skr13.12 Million | Skr122.22 Million | Skr17.21 Million | Skr4.10 Million | ▼ -14.5 pp |
| 2017 | 25.2% | Skr27.16 Million | Skr107.78 Million | Skr30.98 Million | Skr3.81 Million | ▲ +4.4 pp |
| 2016 | 20.8% | Skr14.96 Million | Skr71.84 Million | Skr17.14 Million | Skr2.18 Million | ▼ -8.0 pp |
| 2015 | 28.8% | Skr18.85 Million | Skr65.41 Million | Skr22.39 Million | Skr3.54 Million | ▲ +5.7 pp |
| 2014 | 23.1% | Skr12.96 Million | Skr56.05 Million | Skr15.02 Million | Skr2.06 Million | ▲ +7.1 pp |
| 2013 | 16.0% | Skr6.12 Million | Skr38.18 Million | Skr8.17 Million | Skr2.05 Million | ▼ -24.5 pp |
| 2012 | 40.6% | Skr17.14 Million | Skr42.25 Million | Skr22.48 Million | Skr5.33 Million | ▲ +38.3 pp |
| 2011 | 2.3% | Skr297.00K | Skr12.84 Million | Skr1.59 Million | Skr1.29 Million | — |